Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test
-
Egged Tours Broaden Installation of SaverOne System Across its Entire Bus Fleet
-
Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development
-
Ackroo Announces Re-structuring of BDC loan
-
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones
-
For the Third Year in a Row, Anteriad Makes the Inc. 5000 List
-
Akoustis Receives an Additional Purchase Order for $13 Million XBAW® Filters from Existing Tier-1 Customer
-
Agrify Corporation Announces Results from Annual Meeting of Stockholders
-
Golden Matrix Group Announces Strong Second Quarter Financial Results
-
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2024 and Declaration of Distributions on Common Stock for the Months Ending October
-
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
-
UPSTACK Debuts at No. 101 on the 2024 Inc. 5000
-
STACK Infrastructure’s Heroes of the Sea Charitable Fundraiser Breaks Records and Achieves $2.1 Million in Lifetime Contributions
-
IDI Now Available on Carahsoft’s GSA Schedule
-
8 Rivers and Siemens Energy Partner on Development Program of Carbon Capture Power Generation
-
Obra Capital Partners with Solera Auto Finance in a Management Buyout
-
Auto Insurance Shopping Continued to Rise Even as Rates Stabilized in Q2 2024
-
Cue Biopharma to Host Business Update Call and Webcast
-
Skyward Specialty Enters the Mortgage (Re)insurance Market with Strategic Recruitment of JP Latour
-
Coca-Cola® and the OREO® Brands Become “Besties,” Launch Limited-Edition Drink and Cookie that Perfectly Pair Iconic Brands
-
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
-
JOANN to Hire More Than 5,000 Seasonal Team Members as Holiday Shopping Ramps Up Earlier than Ever
-
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
-
Café Valley Introduces 7UP® and Crush® Orange Flavored Soda Mini Cupcakes
-
World of Good Brands Bolsters Editorial Leadership Team
-
a.k.a. Brands to Present at the Gateway Conference on September 4th, 2024
-
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
-
Acres and LandLeader Forge Partnership to Advance Transparency & Expediency in Rural Land Transactions
-
The court terminated reorganization proceedings for MPG AgroProduction OÜ
-
Notice of Nexstim Plc’s Half-Year Report H1 2024
-
Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved
-
AS Tallink Grupp: Managers’ Transactions
-
Boom DeFi and Financial Times agree on strategic partnership bridging traditional and decentralised finance
-
Fuse Named to Inc. 5000 List of Fastest-Growing Private Companies for Second Time
-
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
-
FTI Consulting Expands Global Construction, Projects & Assets Practice with Two Senior Hires
-
Middlefield Banc Corp. Announces 2024 Third-Quarter Cash Dividend Payment
-
FTI Consulting Expands Global Construction, Projects & Assets Practice with Two Senior Hires
-
Intuitive Machines Reports Second Quarter 2024 Financial Results; Raises Low-end of 2024 Revenue Outlook
-
Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development
-
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
-
Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
-
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
-
Trawick International Introduces Industry-First Travel Insurance Plan with Embedded CFAR Coverage
-
XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
-
ProVen Growth and Income VCT plc: Publication of a supplementary prospectus
-
ProVen VCT plc: Publication of a supplementary prospectus
-
Alliance Trust PLC - Net Asset Value
-
Form 8.3 - Keywords Studios Plc
